Governments urged to commit to buying vaccines from local producers
Medicines Patent Pool wants greater assurance for shots manufacturers investing in mRNA technology
20 November 2024 - 05:00
UPDATED 21 November 2024 - 11:39
The governments of developing countries should give greater assurance to vaccine manufacturers investing in mRNA technology that they will purchase the shots they produce, the head of the Medicines Patent Pool (MPP) said on Tuesday.
“If low- and middle-income countries want regional production, they have to be ready to buy the product. They cannot be off to the side: their part of the deal is providing the demand,” MPP executive director Charles Gore said on the sidelines of a meeting of the mRNA vaccine technology transfer programme in Cape Town...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.